U.S. markets open in 7 hours 37 minutes

Rite Aid Corporation (RAD)

NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
12.57+1.40 (+12.53%)
At close: 4:00PM EST
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bullishpattern detected
MACD

MACD

Previous Close11.17
Open11.17
Bid12.58 x 1200
Ask12.70 x 1000
Day's Range11.11 - 12.80
52 Week Range7.49 - 23.88
Volume6,334,995
Avg. Volume3,685,196
Market Cap684.453M
Beta (5Y Monthly)0.59
PE Ratio (TTM)N/A
EPS (TTM)-6.55
Earnings DateSep 24, 2020
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateOct 14, 1999
1y Target Est8.63
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Overvalued
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
View more
  • MarketWatch

    Rite Aid says it will continue to offer free COVID-19 tests in December

    Shares of Rite Aid Corp. were up 0.1% in after-hours trading on Tuesday after the drugstore chain confirmed that it will continue to offer no-charge COVID-19 testing in December. Rite Aid had announced Tuesday morning that it would begin charging $115 for symptomatic and asymptomatic diagnostic testing starting Dec. 1. The company currently does not charge people who come in for COVID-19 testing at its 301 testing sites. The Department of Health and Human Services said Rite Aid had notified HHS on Nov. 21 that it had conducted more tests than allocated in their contract, and that HHS had requested more funding for Rite Aid in response, according to a statement from Mia Heck, director of external affairs in the office of the assistant secretary for health. A Rite Aid spokesperson declined to comment beyond the news announcement. Rite Aid also on Tuesday announced plans to lower the age requirement for a COVID-19 test to 13 years old from 18 and said it plans to add 1,000 drive-through testing locations. All of the major drugstore chains in the U.S. including CVS Health Corp. and Walgreens Boots Alliance Inc. are offering coronavirus tests. Rite Aid's stock is down 28% so far this year, while the S&P 500 has gained 10.7%.

  • TheStreet.com

    Rite Aid to Expand Covid Testing, Will Charge $115 Per Test

    On Dec. 1 free covid testing at Rite Aid drugstores will be replaced with a $115-per-test program for individuals over age 13.